Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paloma Gijón-Vidaurreta"'
Autor:
Sandra Pérez-Recio, Maria D. Grijota-Camino, Luis Anibarro, Ramón Rabuñal-Rey, Josefina Sabria, Paloma Gijón-Vidaurreta, Virginia Pomar, Mercedes García-Gasalla, Ángel Domínguez-Castellano, Matilde Trigo, María Jesús Santos, Alba Cebollero, Sara Rodríguez, Esther Moga, Anton Penas-Truque, Carmen Martos, M. Jesús Ruiz-Serrano, Erika I. Garcia-de-Cara, Fernando Alcaide, Miguel Santin
Publikováno v:
PLoS ONE, Vol 18, Iss 8 (2023)
Background Interferon-y Release Assays (IGRA) reversions have been reported in different clinical scenarios for the diagnosis of tuberculosis (TB) infection. This study aimed to determine the rate of QuantiFERON-TB Gold Plus (QFT-Plus) reversions dur
Externí odkaz:
https://doaj.org/article/b419b560c6cf49078ebb6c168273e7d6
Autor:
Ana Herranz-Alonso, Carmen Guadalupe Rodríguez-González, Paula Arrabal-Durán, Paloma Gijón-Vidaurreta, Esther Chamorro-de-Vega, María Sanjurjo-Sáez
Publikováno v:
International journal of clinical practice. 71(8)
SummaryObjectives This study evaluates the effectiveness, safety and costs of switching to a rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF) regimen in treatment-experienced HIV-1-infected patients with sustained virological sup
Autor:
José María Bellón, M. Ángeles Muñoz-Fernández, Jose L. Jimenez, Mónica García-Álvarez, María Guzmán-Fulgencio, Paloma Gijón-Vidaurreta, Salvador Resino, Pompeyo Viciana, Enrique Bernal-Morell, Vicente Soriano, María Ángeles Jiménez-Sousa
Publikováno v:
ResearcherID
Our aim was to explore the association among ACSM4 and PECI polymorphisms and AIDS progression in 454 HIV- infected patients never treated with antiretroviral drugs (146 long- term nonprogressors, 228 moderate progressors, and 80 rapid progressors).